TY - CHAP M1 - Book, Section TI - Mouth and Throat A1 - Usatine, Richard P. A1 - Sabella, Camille A1 - Smith, Mindy Ann A1 - Mayeaux, E.J. A1 - Chumley, Heidi S. A1 - Appachi, Elumalai Y1 - 2015 N1 - T2 - The Color Atlas of Pediatrics AB - References1Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470–511.10885988[PubMed: ]2Cherry JD. Contemporary infectious exanthems. Clin Infect Dis. 1993;16(2):199–205.8443297[PubMed: ]3Hahn RG, Knox LM, Forman TA. Evaluation of poststreptococcal illness. Am Fam Physician. 2005;71(10):1949–1954.15926411[PubMed: ]4Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110(17):2747–2771.15505111[PubMed: ]5Pickering LK, Baker CJ, Kimberlin DW, Long SS, et al. In: Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. American Academy of Pediatrics; Elk Grove, IL; 2012.6Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics. 2004;113(4):866–882.15060239[PubMed: ]7Freeman AF, Shulman ST. Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician. 2006;74(7):1141–1148.17039750[PubMed: ] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspediatrics.mhmedical.com/content.aspx?aid=1114870168 ER -